Stock 6499 MEDEON BIODESIGN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Medeon Biodesign, Inc.

Equities

6499

TW0006499007

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 21/06/2024 am IST 		5-day change 1st Jan Change
50.5 TWD +1.20% Intraday chart for Medeon Biodesign, Inc. +21.54% +8.25%
14/06 Medeon International, Inc announced that it expects to receive $4.00004 million in funding from Medeon Biodesign, Inc. CI
12/06 Medeon Biodesign, Inc. Announces Changes to Remuneration Committee CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medeon International, Inc announced that it expects to receive $4.00004 million in funding from Medeon Biodesign, Inc.
CI
Medeon Biodesign, Inc. Announces Changes to Remuneration Committee
CI
Medeon Biodesign, Inc. Announces Changes to Audit Committee
CI
Medeon Biodesign, Inc. Announces Board Changes
CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Medeologix Inc. announced that it expects to receive TWD 315 million in funding from Medeon Biodesign, Inc.
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Medeon Biodesign, Inc.(TPEX:6499) added to S&P Global BMI Index
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Medeon Biodesign, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Medeon Biodesign, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 6499 Stock
  4. News Medeon Biodesign, Inc.